HIGHLIGHTS
- who: Sara M. Steinmann and colleagues from the Institute of, University Regensburg, Franz-Josef-Strauss-Allee, Regensburg, Germany have published the Article: eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma, in the Journal: (JOURNAL) of 24/Nov/2022
- what: The authors investigated the pathogenetic role of eIF4A1 in human HCC and its potential usefulness as a novel molecular target for the development of novel pharmacological strategies.
- future: Although hepatitis B or C virus infection and alcohol abuse remain major HCC risk factors the number of HCC cases related to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.